These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 17102875)

  • 1. DFT study on hydroxy acid-lactone interconversion of statins: The case of fluvastatin.
    Grabarkiewicz T; Grobelny P; Hoffmann M; Mielcarek J
    Org Biomol Chem; 2006 Dec; 4(23):4299-306. PubMed ID: 17102875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DFT study on hydroxy acid-lactone interconversion of statins: the case of atorvastatin.
    Hoffmann M; Nowosielski M
    Org Biomol Chem; 2008 Oct; 6(19):3527-31. PubMed ID: 19082153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding thermodynamics of statins to HMG-CoA reductase.
    Carbonell T; Freire E
    Biochemistry; 2005 Sep; 44(35):11741-8. PubMed ID: 16128575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the conversion of three natural statins from lactone forms to their corresponding hydroxy acid forms and their determination in Pu-Erh tea.
    Yang DJ; Hwang LS
    J Chromatogr A; 2006 Jun; 1119(1-2):277-84. PubMed ID: 16388814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluvastatin and fluvastatin extended release: a clinical and safety profile.
    Asberg A; Holdaas H
    Expert Rev Cardiovasc Ther; 2004 Sep; 2(5):641-52. PubMed ID: 15350166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro.
    Skottheim IB; Gedde-Dahl A; Hejazifar S; Hoel K; Asberg A
    Eur J Pharm Sci; 2008 Apr; 33(4-5):317-25. PubMed ID: 18294823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acid and lactone forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on the induction of MDR1 expression and function in LS180 cells.
    Yamasaki D; Nakamura T; Okamura N; Kokudai M; Inui N; Takeuchi K; Watanabe H; Hirai M; Okumura K; Sakaeda T
    Eur J Pharm Sci; 2009 May; 37(2):126-32. PubMed ID: 19429419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational investigation of hydrogen abstraction from 2-aminoethanol by the 1,5-dideoxyribose-5-yl radical: a model study of a reaction occurring in the active site of ethanolamine ammonia lyase.
    Semialjac M; Schwarz H
    Chemistry; 2004 Jun; 10(11):2781-8. PubMed ID: 15195308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the hydration of carbon dioxide: direct participation of H2O versus microsolvation.
    Nguyen MT; Matus MH; Jackson VE; Vu TN; Rustad JR; Dixon DA
    J Phys Chem A; 2008 Oct; 112(41):10386-98. PubMed ID: 18816037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chiral separation of fluvastatin enantiomers by capillary electrophoresis.
    Trung TQ; Dung PT; Hoan NN; Kim DJ; Lee JH; Kim KH
    Arch Pharm Res; 2008 Aug; 31(8):1066-72. PubMed ID: 18787799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel use of oxidative coupling reactions for determination of some statins (cholesterol-lowering drugs) in pharmaceutical formulations.
    Ashour S; Bahbouh M; Khateeb M
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Mar; 78(3):913-7. PubMed ID: 21237703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and theoretical studies on fluvastatin primary photoproduct formation.
    Jarmużek D; Pedzinski T; Hoffmann M; Siodła T; Salus K; Pluskota-Karwatka D
    Phys Chem Chem Phys; 2017 Aug; 19(33):21946-21954. PubMed ID: 28650504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of acid-base imbalance in statin-induced myotoxicity.
    Taha DA; De Moor CH; Barrett DA; Lee JB; Gandhi RD; Hoo CW; Gershkovich P
    Transl Res; 2016 Aug; 174():140-160.e14. PubMed ID: 27083388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutral and acidic hydrolysis reactions of the third generation anticancer drug oxaliplatin.
    Lucas MF; Pavelka M; Alberto ME; Russo N
    J Phys Chem B; 2009 Jan; 113(3):831-8. PubMed ID: 19143575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulatory effects of low-dose 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor fluvastatin on hepatocyte growth factor-induced angiogenesis: involvement of p38 mitogen-activated protein kinase.
    Uruno A; Sugawara A; Kudo M; Satoh F; Saito A; Ito S
    Hypertens Res; 2008 Nov; 31(11):2085-96. PubMed ID: 19098381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cycloaddition of benzene on Si(100) and its surface conversions.
    Jung Y; Gordon MS
    J Am Chem Soc; 2005 Mar; 127(9):3131-9. PubMed ID: 15740153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theoretical study of 5-aminolevulinic acid tautomerization: a novel self-catalyzed mechanism.
    Erdtman E; Eriksson LA
    J Phys Chem A; 2008 May; 112(18):4367-74. PubMed ID: 18416542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.
    Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET
    Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marked elevation of liver transaminases after high-dose fluvastatin unmasks chronic hepatitis C: safety and re-challenge.
    Chen YW; Lai HW; Wang TD
    Acta Neurol Taiwan; 2007 Sep; 16(3):163-7. PubMed ID: 17966956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of two HMG-CoA reductase inhibitors, pravastatin and pitavastatin, in plasma samples using liquid chromatography-tandem mass spectrometry for pharmaceutical study.
    Deng JW; Kim KB; Song IS; Shon JH; Zhou HH; Liu KH; Shin JG
    Biomed Chromatogr; 2008 Feb; 22(2):131-5. PubMed ID: 17703482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.